A Study of Olaparib and Durvalumab in Prostate Cancer
Part of paid clinical trials in Duarte, California.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT03810105
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Olaparib — DRUGOlaparib 300mg twice daily (600mg total daily dose)
- Durvalumab — DRUGDurvalumab 1500mg IV monthly
Study Details
The purpose of this study is to determine if the combination of olaparib and durvalumab are better than the standard of care for treating prostate cancer.
Key Dates
- Start date
- Mar 7, 2019
- Status verified
- Feb 2024
- Primary completion
- Jul 6, 2023
- Completion
- Jul 6, 2023
Study Design
- Enrollment
- 5 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Castration Sensitive Biochemically Recurrent Prostate CancerCastration Sensitive Biochemically Recurrent Non-Metastatic Prostate Cancer
Primary Outcome Measure
Therapeutic Efficacy as Defined by Number of Participants With an Undetectable PSA [ Time Frame: 1 year ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | - |
| University of Illinois at Chicago | Chicago | Illinois | 60637 | - |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | - |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
Find similar trials in Duarte, CA
By condition
By specialty
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerPHASE3 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona